OSICENT 80 MG
DESCRIPTION Indications Osimertinib is indicated for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small
OSIMERT 80 MG
DESCRIPTION Osimert 80 mg Osimertinib COMPOSITION Osimert Tablet: Each film coated tablet contains Osimertinib mesylate INN 95.4 mg equivalent to
PALBOCENT 125 MG
DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of
PALBONIX 125 MG
DESCRIPTION Product Description: Palbociclib is indicated for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with:
PONAXEN 15 MG
DESCRIPTION Generic Name Ponatinib Other Brand Name Ponaxen Packing 30 Form Tablet Strength 15mg, 45mg Manufacturer Everest Pharmaceuticals Ltd. COMPOSITION
PONAXEN 45 MG
DESCRIPTION Generic Name Ponatinib Other Brand Name Ponaxen Packing 30 Form Tablet Strength 15mg, 45mg Manufacturer Everest Pharmaceuticals Ltd. COMPOSITION
REGONIX 40 MG
Product Description: Regorafenib is an oral multi-kinase inhibitor involved in normal cellular functioning and in pathological processes such as oncogenesis,
RESOLAX 1 MG
Resolax Tablet Prucalopride Succinate 1 mg Everest Pharmaceuticals Ltd. Indications Prucalopride is indicated for symptomatic treatment of chronic constipation in adults
ROXIBAC PLUS 250 _ 500 MG
Roxibac Plus Tablet Cefuroxime Axetil + Clavulanic Acid 250 mg+62.5 mg & 500Mg Julphar Bangladesh Ltd. Indications It is indicated for
